Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Down 0.3%
Tue, 30 Jul 16:9

ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Down 0.3%Image source: KanawatTH/www.istockphoto.com

ALEMBIC PHARMA share price has plunged 5% and is presently trading at Rs 1,175.4.

Meanwhile, the BSE HEALTHCARE index is at 40,152.3 (down 0.3%).

Among the top losers in the BSE HEALTHCARE index today are Torrent Pharma (down 2.4%) and FDC (down 2.4%).

SUVEN PHARMACEUTICALS (up 5.3%) and GRANULES INDIA (up 4.3%) are among the top gainers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 708.1 to Rs 1,175.4, registering a gain of Rs 467.4 (up 66.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,979.9 to 40,152.3, registering a gain of 48.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 101.2%), Lupin (up 97.2%) and Cadila Healthcare (up 96.3%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,411.0 (up 0.1%).

The top gainers among the BSE Sensex today are Tata Motors (up 3.4%) and NTPC (up 3.3%). The most traded stocks in the BSE Sensex are Tata Steel and Axis Bank.

In the meantime, NSE Nifty is at 24,840.9 . Tata Motors and NTPC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,707.2 to 81,411.0, registering a gain of 14,703.8 points (up 22.0%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 10.9% YoY to Rs 1,786 million for the quarter ended March 2024, compared to a profit of Rs 1,611 million a year ago. Net sales rose 7.9% to Rs 15,170 million during the period as against Rs 14,065 million in January-March 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 37.5.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Down 0.3%". Click here!